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Abstract
Wildlife is a global source of endemic and emerging infectious diseases. The control of tuberculosis (TB) in cattle in Britain
and Ireland is hindered by persistent infection in wild badgers (Meles meles). Vaccination with Bacillus Calmette-Gue´rin
(BCG) has been shown to reduce the severity and progression of experimentally induced TB in captive badgers. Analysis of
data from a four-year clinical field study, conducted at the social group level, suggested a similar, direct protective effect of
BCG in a wild badger population. Here we present new evidence from the same study identifying both a direct beneficial
effect of vaccination in individual badgers and an indirect protective effect in unvaccinated cubs. We show that
intramuscular injection of BCG reduced by 76% (Odds ratio = 0.24, 95% confidence interval (CI) 0.11–0.52) the risk of free-
living vaccinated individuals testing positive to a diagnostic test combination to detect progressive infection. A more
sensitive panel of tests for the detection of infection per se identified a reduction of 54% (Odds ratio = 0.46, 95% CI 0.26–
0.88) in the risk of a positive result following vaccination. In addition, we show the risk of unvaccinated badger cubs, but not
adults, testing positive to an even more sensitive panel of diagnostic tests decreased significantly as the proportion of
vaccinated individuals in their social group increased (Odds ratio = 0.08, 95% CI 0.01–0.76; P= 0.03). When more than a third
of their social group had been vaccinated, the risk to unvaccinated cubs was reduced by 79% (Odds ratio = 0.21, 95% CI
0.05–0.81; P= 0.02).
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Introduction
There is growing recognition of the importance of wildlife hosts
in the emergence, spread and maintenance of infectious diseases
that severely compromise human and animal health, inflict major
economic costs and threaten biodiversity [1,2]. Bovine tuberculosis
(TB), caused by infection with Mycobacterium bovis, is a globally
important animal disease and the most serious health threat to the
cattle industry in Britain and Ireland. Over 10% of herds in
England alone were under disease control restrictions at some
point between 2010 and 2011 as a result of incidents of TB,
resulting in the compulsory slaughter of nearly 25,000 cattle [3].
The associated annual costs including testing, research and
compensation exceeded £90M [3].
The control of TB in cattle in Britain and Ireland has been
seriously constrained by the presence of a persistent reservoir of
infection in Eurasian badgers (Meles meles) [4]. There is also
growing evidence implicating badgers in the persistence of M. bovis
infection in parts of mainland Europe, although other wildlife
species currently appear to be more important maintenance hosts
outside of the British Isles [5]. Badger culling has been employed
in Britain and Ireland in an attempt to reduce TB in cattle.
Localised culling trials in the Republic of Ireland (RoI) have
reported some considerable success in reducing incidence of TB in
cattle in these areas [6,7,8], and badgers are now generally culled
in response to local cattle herd breakdowns (CHBs) in the ROI [9].
However, in Britain where the density of badgers is generally
higher and the wider effects of culling have been investigated,
badger culling has resulted in both increases and decreases in
cattle TB [10,11,12,13,14,15]. Also, badgers are a protected and
iconic species in Britain and culling badgers remains highly
controversial [16,17,18].
Vaccination has been used successfully to manage wildlife
reservoirs of infection, but has largely been limited to the control of
acute viral diseases, such as rabies in Europe and North America
[19,20] and Classical Swine Fever, where the vaccination of wild
boar has achieved some success [21,22]. So far, vaccination has
not been used extensively to control chronic bacterial infections,
such as TB in wildlife [23].
Previous work with captive badgers has demonstrated that the
intramuscular administration of Bacillus Calmette-Gue´rin (BCG)
confers a degree of direct protection in vaccinated individuals. In
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e49833
experimental challenge studies, BCG vaccination significantly
reduced disease progression and severity, and excretion of M. bovis
infection in individual badgers [24,25]. Initial results from a
parallel field study showed that vaccination significantly reduced
the incidence of positive responses to a serological test for TB
(Stat-Pak, Chembio Diagnostic Systems Inc., New York, USA)
suggesting a beneficial effect of BCG in reducing disease
progression in wild badgers [24]. That study was undertaken as
part of a blinded-trial where the social group was the designated
treatment unit and the initial analysis did not consider the effects
of vaccination at the level of the individual badger, consequently
factors such as the time individuals entered and exited the study
(e.g. through recruitment, dispersal and mortality) were not
accounted for.
A specific challenge associated with prophylactic vaccination
arises if a high proportion of individuals cannot be vaccinated
before they become infected [26]. This is a particular concern for
the vaccination of badgers against TB because they live in close
contact with one another and their young do not generally emerge
from their underground den (sett) for the first two months of their
life [27]. The argument that many badger cubs will become
infected during this period (i.e. before they can be caught and
vaccinated), has been identified as a key potential constraint on the
effectiveness of badger vaccination as a management tool [28].
Under such circumstances, indirect effects of vaccination may be
important. The concept of non-immunised individuals within a
group or population being ‘protected’ from disease transmission by
the presence and proximity of immune individuals is long
established [29]. The term ‘‘herd immunity’’ was subsequently
coined to describe this phenomenon [30] and has since become an
integral component of the science underpinning human vaccina-
tion programmes [31]. Herd immunity underlies the global
eradication of smallpox, though evidence for it in human TB
vaccination campaigns is limited [32].
In this paper we report further analyses of results from the four-
year clinical field study of the effects of parenteral administration
of BCG in wild badgers. We extend the previous study of the
effects of BCG on wild badgers by investigating the direct effect of
vaccination on individual badgers and the indirect effects on
unvaccinated badgers. Neither approach was possible previously
due to blinding of the data. Data were initially blinded as they
constituted safety and supporting efficacy evidence for a marketing
authorisation for parenterally administered BCG in badgers,
which was subsequently granted in March 2010.
Methods
Ethics statement
All animal procedures were covered by licences issued by the
Home Office and the Veterinary Medicines Directorate, following
approval by ethics panels at The Food and Environment Research
Agency and Animal Health and Veterinary Laboratories Agency.
The study was conducted according to the principles of Good
Clinical Practice [33].
Study area and population
Field work was carried out in an area of mixed woodland and
agricultural land covering approximately 55 km2 in Gloucester-
shire, southwest England, between November 2005 and October
2009. The area was chosen as it is within a region where very high
badger density has been recorded (25.3 badgers/km2 [34]), where
TB is known to be endemic in the badger population [35] and
where there had not been recent badger culling. Badger social
group territories were identified by bait marking [36], with
individuals being assigned to social groups according to the
location of their capture. Social groups were allocated to
‘‘vaccinate’’ or ‘‘control’’ treatment following a baseline trapping
session in summer 2006 [Table S1, Figs. 1 and S1]. Treatments
were allocated at a ratio of 60:40 (vaccinate:control) as this ratio
was determined, through modelling known parameters, to have
the most statistical power to detect a difference between treatments
if one existed (unpublished data). TB may be spatially aggregated
in badger populations [35] and badger social groups may vary
considerably in size [27]. A stratified randomisation process that
accounted for variation in group sizes and prevalence of infection
was accordingly used to allocate treatments between social groups
(see [24] for full details). Once a social group had been allocated as
a vaccinate group, all animals first captured in that group were
vaccinated. Animals originating from vaccinate groups but caught
in subsequent years in a control group were repeat vaccinated
according to their original treatment allocation. To account for
any differences in the force of infection between social groups that
merged and fragmented during the study and those that were
apparently more stable, we derived a ‘super-group’ variable. This
label was assigned to clusters of two to three groups that merged
with or subsequently split from one another during the study
period.
Badger trapping, sampling and vaccination
Badgers were captured in steel mesh traps baited with peanuts
and set for two consecutive nights following a three to ten-day pre-
Figure 1. Configuration of badger social group territories in
the first year of the study. Territories have been derived from bait
marking data and show allocation of vaccine treatment (shaded areas)
and control (open areas). Circles indicate additional main setts located
after the 2006 bait marking for which the territorial boundaries could
not be delineated until the following year, but which were determined
to represent discrete social groups in 2006 and allocated a treatment
accordingly. Additional badger groups may have been present in non-
surveyed areas adjacent to the mapped territories, particularly around
the edge of the study area.
doi:10.1371/journal.pone.0049833.g001
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baiting period. Saturation trapping was carried out, whereby more
traps were deployed in the immediate vicinity of the sett than the
anticipated number of resident badgers. All active setts in the study
area were trapped at least twice a year, other than in 2007 when a
foot and mouth disease outbreak prevented the second trapping
operation from taking place (Table S1). Each badger was
anaesthetised by intra-muscular injection of a combination of
ketamine hydrochloride (100 mg ml21, Vetalar TM V, Pharmacia
& Upjohn, Crawley, UK), medetomidine hydrochloride (1 mg
ml21, Domitor H, Pfizer, Sandwich, UK) and butorphanol tartrate
(10 mg ml21, Torbugesic H, Fort Dodge Animal Health Ltd,
Southampton, UK) at a ratio of 2:1:2 by volume respectively [37].
This was supplemented with inhalant isoflurane when necessary.
Upon first capture each animal was marked with an identifier
microchip (inserted subcutaneously between the shoulders) and a
tattoo on the abdomen with the corresponding unique three-digit
identification number. For each capture event, the trap location,
sex and age class (,1 year = cub, $1 year = adult) were recorded.
Tooth wear (five categories from none (0%) to worn flat (100%))
was recorded as a proxy for age [38]. Clinical samples were taken
from all badgers at each capture event, where possible. These
consisted of tracheal mucus (by catheter); urine (by manual
expression or catheter); faeces (by Microlax enema); and swabs of
any wounds, discharges or abscesses. Blood samples were taken
into heparin and SST BD Vacutainer Blood Collection Tubes
(BD, Plymouth, UK) and processed on the same day. BCG Danish
strain 1331 vaccine (Statens Serum Institut (SSI), Copenhagen,
Denmark) was supplied at 2–86106 colony-forming units (CFU)
per vial. The vaccine was prepared by adding 1 ml of Sauton
diluent to each vial. The vaccine was injected in the left or right
lumbar muscle, following shaving and cleaning of the overlying
skin. All animals allocated to vaccinate groups received 1 ml of
vaccine that had been reconstituted for less than 4 h. BCG vaccine
was administered on recapture at a rate of one dose per calendar
year, resulting in some individuals receiving multiple vaccinations
over the course of the study. After sampling and treatment,
captured badgers were returned to their point of capture and
released.
Diagnostics
We used bacterial culture for M. bovis to identify active excretion
[39] and the Brock (TB) Stat-Pak test [40] as evidence of more
progressed infection for analyses of both a direct and indirect effect
of BCG vaccination. We also used the more sensitive IFNc release
assay (IGRA PPDB – PPDA) for our analyses of an indirect effect
of vaccination in unvaccinated badgers. For our investigation of
the direct effects of vaccination, we substituted the IGRA (PPDB –
PPDA) results with those from an alternative, less sensitive, test
format based on the use of specific M. bovis antigens ESAT-6 and
CFP-10, because the performance of the former test may be
compromised by BCG vaccination leading to reduced specificity
[24,25]. To be as robust as possible, we adopted a ‘‘quadruple
test’’ of infection by combining the outcomes of all four diagnostic
tests (PPDB – PPDA, ESAT-6 & CFP-10, Stat-Pak and culture) to
identify animals likely to be infected at their time of first capture.
The quadruple test was used only as a filtering tool and not as a
response variable in any of the following analyses.
Each of the four diagnostic tests had a different sensitivity and
specificity for detecting M. bovis infection in badgers and we
calculated the range in sensitivity of the combined tests using the
union of the individual probabilities from published data (Table
S2). The sensitivity of the combined triple testV (positive for one or
more of IGRA ESAT-6 & CFP10, Stat-Pak or culture) used in the
investigation of a direct effect of vaccination was calculated to lie
between 61% and 86% (all badgers). The sensitivity of the triple
testUV (positive for one or more of IGRA PPDB-PPDA, Stat-Pak
or culture) used in the investigation of an indirect effect lay
between 85% and 94% for adults and between 57% and 84% for
cubs (Table S2). Each represented the most sensitive means to
detect M. bovis infection in vaccinated and unvaccinated animals,
respectively, in the absence of post-mortem examination. Test
specificity could not be similarly enhanced by taking this approach
but specificity of all tests was relatively high (range 0.93–1.0; Table
S2).
Statistical analyses
(i) Investigating the direct effect of vaccination on
individual badgers. We investigated the impact of vaccination
on the transition from test-negative to test-positive status in
individual badgers using event history analysis. For consistency
with previous analysis we ran separate analyses for test results in
isolation and in combination with each other. The ‘event’ was
therefore one of the following: a positive outcome to each
diagnostic test in isolation (i.e. IGRA ESAT-6 & CFP-10, Stat-Pak
and culture); a positive outcome to Stat-Pak and/or culture when
both were considered (‘‘dual test’’); or a positive result to at least
one of all three tests when considered together (‘‘triple testV’’), at
each capture point after the start of vaccination. We developed
models that assumed a baseline hazard common to all social
groups and used relevant covariates (Table S3) in Cox-propor-
tional hazards models [41]. The risk of an individual being
culture-positive has been shown to be related to the presence of
other culture-positive (i.e. infectious, actively excreting) animals in
its social group [35,42], therefore a covariate describing group
infection status (presence of culture positive badgers) was included
(Table S3). It was not possible to model the multiplicative effects of
two factors using the above approach. We therefore attempted to
model the interaction between group infection status and
treatment as four factors (vaccinated/culture positives present,
unvaccinated/culture positives present, vaccinated/culture posi-
tives absent, unvaccinated/culture positives absent), but there were
insufficient cases of unvaccinated badgers captured in groups with
culture positive badgers present to model this class.
As individuals were captured and tested at intervals and not all
individuals were captured at each trapping session, the data were
interval censored; that is, a disease incidence event would have
occurred at a point prior to testing and therefore should not be
ascribed simply to the sampling point at which it was detected.
Interval censoring leads to bias which impacts on both the
direction and magnitude of the effects of covariates in the Cox
model, the magnitude of which cannot be predicted a priori. We
therefore used the iterative convex minorant algorithm (ICM) as
implemented in the intcox library [43] in the R statistical package
(R Development Core Team 2010) to estimate the regression
coefficients of the Cox model. Since this procedure cannot
estimate standard errors for the regression coefficients, we used a
bootstrapping procedure to create 95% confidence intervals for
the exponent of each coefficient based on 999 re-samples of the
original data. A covariate was considered to be non- significant if
the confidence intervals around the bootstrap estimates included 1.
The final model was obtained through stepwise removal of non-
significant covariates from the full model.
(ii) Investigating the indirect effect of vaccination on
unvaccinated badgers. Although all animals first captured in
vaccinate groups were vaccinated from Autumn 2006 onwards,
only a proportion of the group would have been captured at the
first, or even subsequent, capture event(s). In addition, there was
annual recruitment of cubs into most vaccinate groups, some
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evidence of previously discrete vaccinate and control groups
merging to form a larger vaccinate super-group and, we suspect,
immigration of previously uncaptured animals from control groups
or groups outside of the study. Consequently, at any given capture
event following the start of vaccination the proportion of animals
captured that had been previously vaccinated is likely to have been
less than one and this proportion varied among groups (Table S4).
We used mixed effect models to assess the relationship between M.
bovis infection status at first capture of unvaccinated individuals
from vaccinate social groups and the proportion of all other group
members captured at that time that had been vaccinated
previously. We used the combined outcomes of IGRA PPDB –
PPDA, Stat-Pak and culture (triple testUV) to infer infection, as this
was the most sensitive means to detect M. bovis infection in an
unvaccinated live animal. Analysis of mixed effect models for non-
normal data is problematic because the results of analyses may not
be stable and some methods of estimation lead to bias in the
estimates of model parameters [44]. We therefore used Laplace
approximation [45,46], following the approach used by Rushton
et al. [47], which has the advantage of approximating true GLMM
likelihood and is consequently more robust than using penalised
quasi-likelihood which can lead to biased parameter estimates if
the standard deviation in the random effect is large [44]. We ran
analyses for cubs and adults separately due to the potential for
pseudo-vertical disease transmission to impede vaccination, and
because previous work showed the proportion of infected cubs in a
social group was positively related to the presence of infectious
adult females [35]. We hypothesised that the force of infection
within their group would diminish as an increasing proportion of
the residents were vaccinated. There were insufficient data to
restrict analysis to proportions/numbers of particular age or sex
groups that had been previously vaccinated e.g. breeding females.
We expected any observable effect on adults to be weaker than in
cubs, due to the propensity for adults to travel further from their
resident social group, thus increasing their likelihood of encoun-
tering infection. Also, animals captured for the first time as adults
may have already been infected with M. bovis, prior to other group
members being vaccinated.
We included the proportion of contemporary group residents
that had been previously vaccinated as a continuous variable in a
model including the time point and season when badgers were first
captured (i.e. the point at which they entered the study), along with
the sex of the individual and the presence of culture-positive
animals within their social group as covariates (Table S3). Badger
cubs are generally born at the same time of the year [27] so date of
first capture represents a crude proxy for age at first capture. We
also ran analyses using several categorical classifications (including
the same covariates) whereby the proportion of animals previously
vaccinated was assigned into classes e.g. 0–0.33 etc. for illustrative
purposes to aid the interpretation of the more rigorous continuous
model results. In view of the arbitrary nature of categorisation we
investigated a range of cut-offs, although finer scale categorisation
was limited by sample sizes. Only individuals caught for the first
time during or after the second year of the study were considered
for analysis as this was the first opportunity for animals to have
indirectly benefited from the initial vaccination of other group
members. Social group was included as a random factor to allow
for unmeasured variation associated with repeated sampling of the
same groups. All analyses were undertaken in the R statistical
package (R Development Core Team 2010) using the glmmML
libraries [45].
Results
A total of 793 individual badgers were captured on or after the
second trap event when BCG was first administered. Of these, 400
were captured more than once, making them potentially eligible
for the investigation of the direct effect of vaccination. The
remaining 393 were only eligible for the analysis of an indirect
(herd immunity) effect of vaccination. The number of social groups
varied from year to year due to the recruitment of new groups over
time and, to a lesser extent, the dynamic nature of a handful of
groups, resulting in an increase from 62 to 85 discrete social
groups over the course of the study (Figs. 1 and S1). This included
the formation of eight super-groups and six social groups that were
deemed to have split into two discrete groups in at least one year of
the study. Simple prevalence estimates indicated a reduction in the
population-level prevalence of infection (using the combined
results from IGRA ESAT-6 & CFP-10, Stat-Pak and culture)
over the lifetime of the study (Table S5). Prevalence for the
population as a whole based on the combined outcomes of the
above three tests reduced from 53% in 2006 to 35% in 2009.
Reductions in prevalence were observed in both vaccinate and
control groups (Table S5).
Direct effect of BCG vaccination on individual disease risk
A total of 252 individuals qualified for the event history analysis,
following the removal of those individuals caught only once and
those that were likely to have been infected prior to vaccination.
Vaccination reduced the likelihood of developing a positive test
result (after initially testing negative to all tests) by 76% (Odds
ratio = 0.24, 95% confidence interval (CI) 0.11–0.52; Table 1) and
54% (Odds ratio = 0.46, 95% CI 0.26–0.88; Table 1), respectively,
using the dual and triple diagnostic tests for M. bovis. There was no
detectable effect of vaccination on the risk of a positive test result
for culture alone (data not shown). Badgers were significantly more
likely to test positive if there was at least one other culture-positive
badger captured in its social group (all tests; Table 1). Male
badgers were three times (Odds ratio = 3.01, 95% CI 1.44–5.55)
more likely to become positive for one or more of the diagnostic
tests than females (triple testV; Table 1). There was no detectable
effect on risk of an individual developing a positive result to any
test associated with age, social group membership or the number
of individuals captured in its social group (data not shown).
Indirect effect of BCG vaccination on disease risk in
unvaccinated individuals
In total, 121 adults and 185 cubs (all unvaccinated at the time of
capture) were included in the analysis of an indirect effect of
vaccination. Of these, 42 (34.7%) adults and 39 cubs (21.1%)
tested positive to one of the three diagnostic tests at first capture.
This compared to a prevalence of 51.6% (adults) and 32.8% (cubs)
in control groups over the same time period. The probability of an
unvaccinated cub from a vaccinate group testing positive to M.
bovis was significantly inversely related to the proportion of badgers
trapped in the same social group at the same capture event that
had previously been vaccinated (Odds ratio = 0.08, 95% CI 0.01–
0.76; P = 0.03; Table 2). However, the probability of an
unvaccinated adult testing positive to M. bovis was not significantly
related to the proportion of group members captured concurrently
that had been previously vaccinated (Odds ratio = 0.59, 95% CI
0.06–5.59; P = 0.64).
When we assigned the proportion of previously vaccinated
animals to discrete categories, there was a consistent trend for the
highest levels of vaccination to show the greatest reduction in risk
to unvaccinated cubs (Table S6) The reduced risk of an
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unvaccinated cub yielding a positive test result ranged between
79% and 86% for the highest levels of vaccination in the three
categorical models, although this only approached statistical
significance in one of the models (Table S6). For example, the
probability of an unvaccinated cub testing positive to M. bovis was
reduced by 79% when more than one third of the contemporary
group residents had been vaccinated previously (Odds ratio = 0.21,
95% CI 0.05–0.81; P = 0.02; Fig. 2).
There was a strong positive association between unvaccinated
cubs and adults that tested positive for M. bovis, and the presence at
capture of culture-positive, i.e. M. bovis-excreting, animals in the
same social group (Table 2). Adult male badgers were almost four
times more likely to yield a positive result than adult females (Odds
ratio = 3.7, 95% CI 1.30–10.53; P = 0.01; Table 2). Interactions
between significant main effects in the model were investigated but
none were found to be significant (data not shown).
Discussion
Vaccination was associated with a significantly lower risk of an
individual badger testing positive to both a triple diagnostic test for
TB infection and a dual diagnostic test as a proxy for more
advanced infection. In the absence of associated post-mortem data,
tests based on measurement of an immune response are not proof
Table 1. Effects of BCG vaccination on the risk of individual badgers testing positive to a suite of diagnostic tests for M. bovis.
Diagnostic test factor odds ratioa SDb lower 95% CI upper 95% CI
IGRA (ESAT-6/CFP-10) Presence of culture-positive badgers 6.43 2.24 3.25 12.53
Vaccinated previously 0.42 0.14 0.23 0.84
Sex (male) 2.44 0.89 1.19 4.30
Stat-Pak Presence of culture-positive badgers 4.85 2.68 1.87 10.88
Vaccinated previously 0.15 0.22 0.06 0.42
Culture Presence of culture-positive badgers 3.99 1.54 1.77 7.65
Stat-Pak or culture (dual test) Presence of culture-positive badgers 7.92 3.37 3.42 16.37
Vaccinated previously 0.24 0.43 0.11 0.52
Triple testV
c Presence of culture-positive badgers 6.20 2.33 3.14 11.48
Vaccinated previously 0.46 0.12 0.26 0.88
Sex (male) 3.01 1.44 1.44 5.55
Outcome of the final event analysis model showing the individual risk of testing positive for each of the diagnostic tests and test combinations, SD and 95% confidence
intervals associated with different explanatory factors. Only significant factors are listed.
aOdds ratios are equivalent to the mean exponent of the coefficient (exp(ß)) and represent change in odds associated with an individual badger testing positive for M.
bovis in relation to the relevant covariate being assessed. Odds ratio ,1 =decreased odds (negative ß coef.); .1= increased odds (positive ß coef.).
bStandard deviation of the coefficient.
cTriple testV is positive for one or more of IGRA (ESAT-6/CFP-10), Stat-Pak, or culture.
doi:10.1371/journal.pone.0049833.t001
Table 2. Factors affecting the likelihood of unvaccinated badgers in vaccinate groups testing positive to any of the following
diagnostic tests: IGRA (PPDB – PPDA); Stat-Pak; culture.
odds ratioa SEb lower 95% CI upper 95% CI z-valuec p
Cubs
Interceptd 0.26 0.50 0.10 0.68 22.73 0.006
Presence of culture-positive badgers 3.86 0.53 1.37 10.90 2.55 0.01
Proportion of group previously
vaccinatede
0.08 1.17 0.01 0.76 22.19 0.03
Adults
Intercept 0.13 0.53 0.05 0.37 23.84 ,0.001
Presence of culture-positive badgers 6.50 0.60 1.99 21.24 3.11 0.002
Sex (male) 3.70 0.53 1.30 10.53 2.46 0.01
The proportion of badgers previously vaccinated is modelled as a continuous variable. Badger social group was fitted as a random factor and only significant factors are
listed.
aOdds ratios are equal to the mean exponent of the coefficient (exp(ß)) and represent change in the odds associated with an individual badger testing positive for M.
bovis in relation to the relevant covariate being assessed. Odds ratio ,1 =decreased odds (negative z-value); .1= increased odds (positive z-value).
bStandard error of the coefficient.
cCoefficient divided by the SE of the coefficient.
dThe intercept represents the odds of testing positive for M. bovis for an individual badger in a social group without culture-positive individuals and where no other
group members have been vaccinated.
eThe number of other previously vaccinated badgers divided by the total number of other badgers caught in a social group at the time that an unvaccinated badger
was first caught and tested.
doi:10.1371/journal.pone.0049833.t002
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positive of TB infection. Similarly, the absence of a positive test
result does not mean the individual is certainly free of infection.
However, the triple testV used here is the most sensitive and
specific measure of M. bovis infection in a live vaccinated badger
and so provides confidence that these results are biologically
meaningful.
The effect of vaccination on the triple testV outcome was to
reduce the risk of a positive result by 54% in vaccinated
individuals. Without post-mortem data it was not possible to
ascertain what proportion of the triple testV-negative, vaccinated
badgers were protected from infection and what proportion still
acquired infection, but were not detected using the triple testV. It is
unsafe to assume that triple testV negativity equates to the absence
of infection. A greater estimate of vaccine effect (76%) was
observed with the dual test. The IGRA (ESAT-6/CFP-10) was
absent from the dual test. As the IGRA is more sensitive than
either the Stat-Pak or culture at detecting M. bovis infection in live
badgers, this result was not entirely unexpected. Given that
badgers are less likely to be dual test-positive if they are at an
earlier stage of the disease process [48], this result is consistent with
an additional impact of vaccination on the prevention of disease
progression in those vaccinated animals that still succumbed to
infection.
In addition to demonstrating a significant direct benefit of BCG
vaccination in individual badgers, we show a significant indirect
effect of vaccination on unvaccinated cubs born into vaccinated
groups. We conclude from these findings that unvaccinated,
susceptible badger cubs were indirectly protected from disease
transmission through a ‘‘herd immunity’’ effect, at least up to the
point at which they were above ground and could be trapped and
vaccinated. Whilst we cannot categorically rule out other potential
mechanisms for this result, it is unlikely that unvaccinated cubs
were afforded direct protection from maternal transfer of
antibodies arising from BCG vaccination of the mother (passive
immunity) as there is no evidence of a significant protective effect
in cubs from maternal antibody transfer in naturally infected
badger populations [49], where the antigen load would be
expected to be higher than following vaccination. The probability
of BCG being transferred from mother to cub via suckling or
across the placenta (vertical transmission) is extremely low as there
is no evidence of excretion and minimal evidence of dissemination
of BCG in vaccinated individuals [50]. However, even in the
unlikely event that some unvaccinated cubs were afforded
protection directly from their mothers through either of the above
mechanisms, the practical implications of these results remain
unchanged. The failure to detect a significant herd effect in adults
may be partly explained by differences in their ranging behaviour.
Adults are more likely to range further than cubs, leading to a
higher risk of encountering direct or indirect sources of infection
outside of their usual social environment, for example from
badgers or their latrines in unvaccinated control groups, neigh-
bouring groups of unknown infection status or from other species.
A contributing factor to the observed difference is that animals first
captured as adults in a vaccinated group may not have been
resident in that group and/or may have already been infected
prior to the start of BCG vaccination.
The crude categorisation of the proportion of vaccinated
badgers into discrete classes did not permit the identification of
a ‘‘vaccination threshold’’ beyond which a significant herd effect in
cubs is likely to occur, but these results clearly demonstrate an
increasing indirect benefit of vaccination to susceptible badger
cubs as an increasing proportion of their social group is
vaccinated.
The presence of infectious individuals within a social group
represents a high risk of infection for susceptible residents. An
individual badger was on average nearly eight times more likely to
yield a positive dual-test result (associated with increased disease
severity or progression) where at least one other badger captured
in its social group was found to be excreting M. bovis, than if no
other badgers in the group were found to be excreting at the time
of capture. This result is not surprising given the high degree of
sociality and territoriality among badgers and is consistent with
findings from a long-term field study of M. bovis infection in
badgers which showed the proportion of culture-positive animals
in a group to be the most significant factor influencing the risk of
other individuals becoming culture positive within any given year
[35,42]. From a disease management perspective, it is noteworthy
that the significant reductions in infection risk to individual
badgers as a result of vaccination were apparent, even in the
presence of individuals with evidence of advanced infection within
the social group and within a relatively short period of time since
the start of vaccination.
Vaccination of badgers with BCG appears to be beneficial in at
least two ways: by directly reducing the TB burden in vaccinated
individuals [24,25] and by indirectly reducing the risk of
unvaccinated cubs acquiring infection, most likely through a herd
immunity effect on this susceptible component of the badger
population. Indirect ‘protection’ bestowed upon juveniles before
they become accessible for vaccination themselves could be an
important contribution to the success of vaccinating wildlife.
Heterogeneity in contact and transmission rates among human
communities influences the magnitude of herd immunity and in
turn its contribution to the success of mass immunisation
programmes [31]. The stable social structure of badgers and
relatively limited contact between groups [51] has previously been
shown to impede disease spread [35,42]. The marked difference in
the indirect impact of vaccination on adults and cubs observed in
the present study indicates another way in which the social
organisation of badger populations may influence disease trans-
mission among age classes within the social group, although we
might expect to see a similarly protective effect in adults over a
longer time period as the benefits of herd immunity accrue in the
population. Contact patterns among other wild animals are likely
to be equally important in determining the impact of vaccination
in controlling disease. These results also emphasise the importance
of considering indirect as well as direct measures of vaccine
efficacy when evaluating vaccination as a strategy for wildlife
disease control.
Figure 2. Decreasing risk of an unvaccinated badger cub
testing positive to a triple diagnostic test for M. bovis infection
as the proportion of vaccinated badgers in its social group
increases. The number of cubs within each category is shown.
doi:10.1371/journal.pone.0049833.g002
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Conclusion
Vaccinating free-living wild badgers with BCG significantly
reduced the risk of an individual developing a positive result to a
range of diagnostic tests used as a proxy for M. bovis infection. In
particular, an additional protective effect was observed using a
dual test associated with more advanced/severe disease. More-
over, we have demonstrated an indirect benefit of vaccination for
susceptible, unvaccinated badger cubs before they became
available for vaccination themselves. Together, these results
provide additional insights into the nature of the protective effect
of BCG vaccination of wild badgers in their natural social setting.
Our findings should be considered in light of the relatively short
time scale over which the beneficial effects of vaccination were
observed.
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